BMC Rheumatology does not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field. Specific criteria for other article types can be found in the submission guidelines.
Aims and scope
Aims and scope
BMC Rheumatology is an open access, peer-reviewed journal that considers pre-clinical, translational and clinical articles on all aspects of the prevention, treatment and management of rheumatological diseases, related systemic and inflammatory conditions and associated comorbidities, as well as epidemiology, education, pathophysiology, genetics, and drug development.  Â
Annual Journal Metrics
-
2022 Citation Impact
2.2 - 2-year Impact Factor
2.9 - 5-year Impact Factor
0.891 - SNIP (Source Normalized Impact per Paper)
0.703 - SJR (SCImago Journal Rank)2023 Speed
24 days submission to first editorial decision for all manuscripts (Median)
247 days submission to accept (Median)2023 Usage
398,220 downloads
294 Altmetric mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication